U.S. stocks traded lower Thursday, with the Nasdaq Composite down 4.51% to 24,576.49, the S&P 500 down 3.33% to 7,432.77 and the Dow Jones Industrial Average down 2.51% to 52,016.25. Information technology shares fell 5.7%, while consumer staples rose 0.1%. Cardinal Health gained about 3% after reporting quarterly adjusted EPS of $3.26, above the $2.94 analyst estimate, and sales of $67.513 billion, ahead of the $66.588 billion consensus, while raising its FY27 adjusted EPS guidance above estimates. Applovin, Xeris Biopharma and Krispy Kreme posted gains of 32%, 28% and 27%, respectively, while MNTN, Veracyte and PureCycle Technologies fell 54%, 55% and 35%. Oil and gold rose, while silver and copper declined. European shares were mostly higher, and Asian markets closed mostly higher despite a 1.79% drop in Japan's Nikkei 225. U.S. initial jobless claims fell to 189,000, while third-quarter productivity rose 3.6% and unit labor costs fell 0.7%. An earlier Nov. 5, 2026 update cited different intraday levels, including a 5.24% Nasdaq decline and a 3.51% S&P 500 drop; it also noted that the major indexes remained above their 200-day averages and that the S&P 500 and Dow retained gains over 2025 levels. Historical market data and corporate dividend records provided additional longer-term context.